Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): A phase 3 open-label randomised study

  1. Cortes, J.
  2. O'Shaughnessy, J.
  3. Loesch, D.
  4. Blum, J.L.
  5. Vahdat, L.T.
  6. Petrakova, K.
  7. Chollet, P.
  8. Manikas, A.
  9. Diéras, V.
  10. Delozier, T.
  11. Vladimirov, V.
  12. Cardoso, F.
  13. Koh, H.
  14. Bougnoux, P.
  15. Dutcus, C.E.
  16. Seegobin, S.
  17. Mir, D.
  18. Meneses, N.
  19. Wanders, J.
  20. Twelves, C.
Revista:
The Lancet

ISSN: 0140-6736

Any de publicació: 2011

Volum: 377

Número: 9769

Pàgines: 914-923

Tipus: Article

DOI: 10.1016/S0140-6736(11)60070-6 GOOGLE SCHOLAR